Barjaktarevic IZ, Buhr RG, Wang X, et al. Int J Chron Obstruct Pulmon Dis. 2019;14:2927–2938.
The authors have advised that there is an error in the Funding section on page 2935.
The correct funding statement is as follows:
This study was supported by R01HL125432-01A1 (MBD), T32HL007106-41 (RMB), and TL1TR001883-01
(RGB). SPIROMICS was supported by contracts from the NIH/NHLBI (HHSN268200900013C,
HHSN2682009 00014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C,
HHSN268200900019C, and HHSN268200900020C) and supplemented by contributions made through
the Foundation for the NIH and the COPD Foundation from AstraZeneca/MedImmune, Bayer,
Bellerophon Therapeutics, Boehringer-Ingelheim Pharmaceuticals, Inc., Chiesi Farmaceutici
S.p.A., Forest Research Institute, Inc., GlaxoSmithKline, Grifols Therapeutics, Inc.,
Ikaria, Inc., Nycomed GmbH, Takeda Pharmaceutical Company, Novartis Pharmaceuticals
Corporation, ProterixBio; Regeneron Pharmaceuticals, Inc., Sanofi, and Sunovion. The
PRM analyses were supported by NHLBI HL122438 and HL138188. Mehrdad Arjomandi was
supported by a grant from the Flight Attendant Medical Research Institute.
The authors apologize for this error.